246 related articles for article (PubMed ID: 25303560)
1. The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942.
Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
FEBS J; 2015 Jan; 282(1):54-64. PubMed ID: 25303560
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalase-peroxidase KatG W78F mutant from Synechococcus elongatus PCC7942 in complex with the antitubercular pro-drug isoniazid.
Kamachi S; Hirabayashi K; Tamoi M; Shigeoka S; Tada T; Wada K
FEBS Lett; 2015 Jan; 589(1):131-7. PubMed ID: 25479089
[TBL] [Abstract][Full Text] [Related]
3. The tuberculosis prodrug isoniazid bound to activating peroxidases.
Metcalfe C; Macdonald IK; Murphy EJ; Brown KA; Raven EL; Moody PC
J Biol Chem; 2008 Mar; 283(10):6193-200. PubMed ID: 18056997
[TBL] [Abstract][Full Text] [Related]
4. Binding of the antitubercular pro-drug isoniazid in the heme access channel of catalase-peroxidase (KatG). A combined structural and metadynamics investigation.
Vidossich P; Loewen PC; Carpena X; Fiorin G; Fita I; Rovira C
J Phys Chem B; 2014 Mar; 118(11):2924-31. PubMed ID: 24568093
[TBL] [Abstract][Full Text] [Related]
5. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP
Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074
[TBL] [Abstract][Full Text] [Related]
6. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.
Mo L; Zhang W; Wang J; Weng XH; Chen S; Shao LY; Pang MY; Chen ZW
Microb Drug Resist; 2004; 10(4):269-79. PubMed ID: 15650370
[TBL] [Abstract][Full Text] [Related]
8. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function.
Kapetanaki SM; Chouchane S; Yu S; Zhao X; Magliozzo RS; Schelvis JP
Biochemistry; 2005 Jan; 44(1):243-52. PubMed ID: 15628865
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
[TBL] [Abstract][Full Text] [Related]
13. The 2.2 Å resolution structure of the catalase-peroxidase KatG from Synechococcus elongatus PCC7942.
Kamachi S; Wada K; Tamoi M; Shigeoka S; Tada T
Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):288-93. PubMed ID: 24598912
[TBL] [Abstract][Full Text] [Related]
14. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
Yu S; Girotto S; Lee C; Magliozzo RS
J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
[TBL] [Abstract][Full Text] [Related]
15. Modification of the active site of Mycobacterium tuberculosis KatG after disruption of the Met-Tyr-Trp cross-linked adduct.
Kapetanaki SM; Zhao X; Yu S; Magliozzo RS; Schelvis JP
J Inorg Biochem; 2007 Mar; 101(3):422-33. PubMed ID: 17188362
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
[TBL] [Abstract][Full Text] [Related]
17. Isonicotinic acid hydrazide conversion to Isonicotinyl-NAD by catalase-peroxidases.
Wiseman B; Carpena X; Feliz M; Donald LJ; Pons M; Fita I; Loewen PC
J Biol Chem; 2010 Aug; 285(34):26662-73. PubMed ID: 20554537
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase.
Zhao X; Yu S; Magliozzo RS
Biochemistry; 2007 Mar; 46(11):3161-70. PubMed ID: 17309235
[TBL] [Abstract][Full Text] [Related]
19. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).
Wengenack NL; Todorovic S; Yu L; Rusnak F
Biochemistry; 1998 Nov; 37(45):15825-34. PubMed ID: 9843388
[TBL] [Abstract][Full Text] [Related]
20. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.
Saint-Joanis B; Souchon H; Wilming M; Johnsson K; Alzari PM; Cole ST
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):753-60. PubMed ID: 10051449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
